Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 14/20 | 0.89 |
| ▸ | MMP2 | P08253 | 12/20 | 0.89 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.69 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.69 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.69 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.61 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7378962 | 1.00 | MMP9 (0.89) | MMP9MMP2HDAC8HDAC6HDAC2 | |
| SCHEMBL7379195 | 0.92 | MMP9 (0.84) | MMP9MMP2HDAC8HDAC6HDAC2 | |
| SCHEMBL7379197 | 0.92 | MMP9 (0.84) | MMP9MMP2HDAC8HDAC6HDAC2 | |
| SCHEMBL7382067 | 0.91 | MMP9 (0.82) | MMP9MMP2HDAC8HDAC6HDAC2 | |
| SCHEMBL7382065 | 0.91 | MMP9 (0.82) | MMP9MMP2HDAC8HDAC6HDAC2 | |
| SCHEMBL3875616 | 0.91 | MMP9 (0.83) | MMP9MMP2HDAC8HDAC6HDAC2 | |
| SCHEMBL6720186 | 0.89 | MMP9 (0.89) | MMP9MMP2KCNA5MEN1POLB | |
| SCHEMBL5191094 | 0.89 | MMP9 (0.89) | MMP9MMP2KCNA5MEN1POLB | |
| SCHEMBL7374860 | 0.88 | MMP9 (0.78) | MMP9MMP2KCNA5 | |
| SCHEMBL7379813 | 0.88 | MMP9 (0.78) | MMP9MMP2KCNA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0934267-B1 | ALPHA-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | UPJOHN CO (US) | 2002-01-30 | — | — | EP | claimed |
| EP-0934267-A1 | $g(a)-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | PHARMACIA & UPJOHN COMPANY (US) | 1999-08-11 | — | — | EP | claimed |
| US-5804593-A | FOR TREATMENT OF CONNECTIVE TISSUE DEGRADATION, OSTEO-, RHEUMATOID-, AND SEPTIC ARTHRITIS; OSTEOPENIAS, OSTEOPOROSIS, CORNEAL ULCERATION, PERIDONTAL DISEASE, GASTRIC ULCERS. | PHARMACIA & UPJOHN COMPANY (US) | 1998-09-08 | — | — | US | claimed |
| WO-1998017645-A1 | α-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | PHARMACIA & UPJOHN COMPANY (US) | 1998-04-30 | — | — | WO | claimed |
| EP-0934267-B1 | ALPHA-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | UPJOHN CO (US) | 2002-01-30 | — | — | EP | disclosed |
| EP-0934267-A1 | $g(a)-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | PHARMACIA & UPJOHN COMPANY (US) | 1999-08-11 | — | — | EP | disclosed |
| US-5804593-A | FOR TREATMENT OF CONNECTIVE TISSUE DEGRADATION, OSTEO-, RHEUMATOID-, AND SEPTIC ARTHRITIS; OSTEOPENIAS, OSTEOPOROSIS, CORNEAL ULCERATION, PERIDONTAL DISEASE, GASTRIC ULCERS. | PHARMACIA & UPJOHN COMPANY (US) | 1998-09-08 | — | — | US | disclosed |
| WO-1998017645-A1 | α-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | PHARMACIA & UPJOHN COMPANY (US) | 1998-04-30 | — | — | WO | disclosed |